Modeling Oxygenator Performance and Biocompatibility
Blood oxygenators have revolutionized the treatment of heart disease since the introduction of this technology almost 50 years ago. Today approximately 500,000 oxygenators are employed annually worldwide. While the majority of patients temporarily supported by these devices suffer no significant complications, for a certain percentage, particularly the very young (neonates), the elderly, and the very sick, passage of blood through the extracorporeal circuit is poorly tolerated. Blood clotting in the oxygenator is of particular concern, since it can lead to bleeding from surgical incisions, stroke, and device failure. Building oxygenators that are more efficient and cause fewer hemostatic alterations would provide direct patient benefit and widen the applicability of these devices.

Researchers are utilizing computational fluid dynamics (CFD) to model blood flow through commercial membrane oxygenators. Since blood has a tendency to clot where flow is sufficiently slow or in zones of recirculation, the ability of CFD to predict the regions of the adult oxygenator where blood clots form is verified by directly comparing CFD results with maps showing regions likely to develop clots. These oxygenator maps of thrombotic deposition have been made by collecting, sectioning, and photographically analyzing oxygenators used in the clinic. CFD can also be used to predict how well an oxygenator is transporting oxygen to blood flowing in various regions of the device. Generally, in regions where blood flow is relatively slow, oxygen transfer is less efficient. Researchers are therefore using CFD to model oxygen transport at various sites within the adult oxygenator and attempting to predict what level of blood oxygenation can be expected at the outlet of the device. To verify model results a variety of imaging techniques are being used to quantify blood flow patterns within the oxygenators.